FDA Signals Tougher Stance on Required Trial-Data Postings FDA Signals Tougher Stance on Required Trial-Data Postings

The FDA took a long-awaited step to address failures by trial sponsors to post study results on ClinicalTrials.Gov. Experts tracking the issue welcomed the move but called for more consistent FDA action.Medscape Medical News
Source: Medscape Business of Medicine Headlines - Category: Pharmaceuticals Tags: Internal Medicine News Source Type: news